WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Brett Condie
Associate
Employee Benefits and Compensation
New York
bcondie@wsgr.com

D212-497-7771

Download vCard
Open PDF

Brett Condie is an associate in the New York office of Wilson Sonsini Goodrich & Rosati. Brett’s practice focuses on employee benefits and compensation law for private and public companies, with an emphasis on start-up, emerging growth, and venture-backed companies. Brett advises clients on a wide range of compensation and benefits matters, including the design, drafting, and administration of equity compensation programs and the associated tax and securities law considerations. He also advises clients on executive compensation programs such as employment, bonus, severance, change in control, and retention agreements. 

Also active in the firm’s transactional practice, Brett has played a key role in many corporate mergers and acquisitions, representing both buyers and sellers on the compensation-related aspects of these transactions.

Experience

Brett Condie is an associate in the New York office of Wilson Sonsini Goodrich & Rosati. Brett’s practice focuses on employee benefits and compensation law for private and public companies, with an emphasis on start-up, emerging growth, and venture-backed companies. Brett advises clients on a wide range of compensation and benefits matters, including the design, drafting, and administration of equity compensation programs and the associated tax and securities law considerations. He also advises clients on executive compensation programs such as employment, bonus, severance, change in control, and retention agreements. 

Also active in the firm’s transactional practice, Brett has played a key role in many corporate mergers and acquisitions, representing both buyers and sellers on the compensation-related aspects of these transactions.

Education
  • LL.M., Georgetown University Law Center, 2017
  • J.D., Georgetown University Law Center, 2016

    Pro Bono Honors

  • B.A., Political Science, Brigham Young University, 2009

    Minor in Business Management

Admissions
  • State Bar of New York
Credentials
Education
  • LL.M., Georgetown University Law Center, 2017
  • J.D., Georgetown University Law Center, 2016

    Pro Bono Honors

  • B.A., Political Science, Brigham Young University, 2009

    Minor in Business Management

Admissions
  • State Bar of New York
Focus Areas
  • Employee Benefits and Compensation
Recent Insights
Client Highlights
Wilson Sonsini Advises Amaero on IPO
On October 14, 2026, Amaero, a leading U.S.-based producer of high-value refractory and titanium alloy spherical metal powders for additive manufacturing (AM) and advanced manufacturing, and a pioneer in Powder Metallurgy Hot Isostatic Pressing (PM-HIP) manufacturing of large near-net-shape components, announced the pricing of its initial public offering of 4,705,883 shares of its common stock at a price of $4.25 per share. Amaero has also granted the underwriters a 30-day option to purchase up to an additional 705,882 shares of its common stock at the initial public offering price, less underwriting discounts and commissions. Wilson Sonsini Goodrich & Rosati advised Amaero on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Iambic Therapeutics on $150 Million Initial Public Offering
Wilson Sonsini advised Iambic Therapeutics, a clinical-stage life sciences and technology company advancing novel medicines using its AI-driven platform, in connection with the company’s $150 million initial public offering (IPO). Iambic issued 9,375,000 shares of its common stock at a public offering price of $16 per share, with a 30-day option for the underwriters to purchase up to an additional 1,406,250 shares. Iambic’s common stock began trading on the Nasdaq Global Select Market on October 15, 2026, under the ticker symbol “IAM.”
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Cookie Settings
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.